ANN ARBOR, Mich., June 4, 2007 - ProQuest and Scopus are pleased to announce a unique reciprocal searching and linking partnership that will expand the research capabilities of mutual customers of CSA Illumina™ and Scopus®. This integration will enable users of CSA Illumina to find 4,500 Scopus titles in natural sciences, business, and economics directly integrated in their search results. In turn, Scopus users will be able to view records from selected leading ProQuest databases in social sciences from the CSA Illumina platform.

CSA Illumina, from ProQuest, is a robust digital platform for bibliographic and full-text searching of more than 100 databases covering social sciences.  Scopus is the largest abstract and citation database of research literature and quality web sources with smart tools to track, analyze and visualize research, covering over 15,000 titles from more than 4,000 international publishers.

Mutual users will be able to cross-search the comprehensive and superior coverage of both well-established products in either single interface without any extra effort. Additional search results will be seamlessly integrated in the results set with a direct link to the original record on the native product and to full text if available. 

"ProQuest selectively considers partnerships that improve discovery… that can open new, more direct paths to high quality research.  This is a great example of that strategy in action," said Matt Dunie, president of ProQuest. "Now on both platforms, a single search will now provide researchers with improved depth and breadth of content that supports research in STM, business, and the social sciences."

Key bibliographic records from Scopus in natural sciences, business, and economics will be made available on the CSA Illumina platform. In turn, high quality titles in social sciences on the CSA Illumina platform, such as CSA Sociological Abstracts and Applied Social Sciences Index and Abstracts, will be made available on Scopus.

"This partnership makes literature research even more effective using Scopus and CSA Illumina," said Jaco Zijlstra, Scopus Director.  "Wherever users start their research, they can be sure to find the most comprehensive coverage of science, technology, medicine, and social sciences literature available, while still taking advantage of all features that Scopus and CSA Illumina offer."

This reciprocal linking capability is available at no additional charge to customers who have both licensed the selected content from both CSA Illumina and Scopus, offering these customers even more return on their investment. Mutual customers will receive a notification when the linking agreement is activated at their institution. 

About ProQuest
ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning. A global leader in serving libraries of all types, ProQuest offers the expertise of such respected brands as Chadwyck-Healey™, UMI®, SIRS®, and eLibrary®. With Serials Solutions®, Ulrich's™, RefWorks®, COS™, Dialog® and now Bowker® part of the ProQuest brand family, the company supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience.

More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others. Inspired by its customers and their end users, ProQuest is working toward a future that blends information accessibility with community to further enhance learning and encourage lifelong enrichment.

For more information, visit www.proquest.com or the ProQuest parent company website, www.cig.com.

About Scopus
Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality web sources with smart tools to track, analyze and visualize research. Scopus is designed and developed with over 300 users and librarians internationally. Its unique database contains abstracts and references from over 15,000 peer reviewed journals from 4,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also integrates web & patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool.
For more information about Scopus please visit www.info.scopus.com.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in 77 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).